cmtm6 Knockout A-375 Cell Line
Cat.No.:
EDC07544
Species:
Human
Cell Name:
A-375
Gene:
cmtm6
Gene ID:
54918
Size:
1×10⁶cells
cmtm6 Knockout A375 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07544 |
|---|---|
| Product Name | cmtm6 Knockout A375 Cell Line |
| Species | Human |
| Cell Line | A-375 |
| Cellosaurus ID | CVCL_0132 |
| Gene ID | |
| Cell Line Synonyms | A 375, A375, A375-MEL, A375-mel, A375mel, 375 |
| Gene | cmtm6 |
| Digestion Time | ~3 min |
| Associated Diseases | Melanoma |
| Morphology | Adherent |
| Passage Ratio | 1:3~1:4 |
| Complete Culture Medium | DMEM+10% FBS+1% GlutaMax |
| Freezing Medium | 95% complete culture medium+5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: A-375 | STR Info (Cell bank) Cell Line: A-375 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 11 | 12 | 11 | 12 |
| D2S1338 | 16 | 24 | 16 | 24 |
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 12 | 12 | ||
| D7S820 | 9 | 9 | ||
| D8S1179 | 11 | 14 | 11 | 14 |
| D13S317 | 11 | 14 | 11 | 14 |
| D16S539 | 9 | 9 | ||
| D18S51 | 12 | 17 | 12 | 17 |
| D19S433 | 13 | 14.2 | 13 | 14.2 |
| D21S11 | 29 | 30 | 29 | 30 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 15 | 9 | 15 |
| Penta E | 10 | 12 | 10 | 12 |
| TH01 | 8 | 8 | ||
| TPOX | 8 | 10 | 8 | 10 |
| vWA | 16 | 17 | 16 | 17 |
| D6S1043 | 11 | 14 | ||
| D12S391 | 18 | 21 | 18 | 21 |
| D2S441 | 11 | 11 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying cmtm6 function, cmtm6 Knockout A-375 Cell Line or cmtm6 overexpression A-375 Cell Line?
The choice depends on whether you are studying CMTM6's stabilizing function on endogenous PD-L1 or its sufficiency to enhance PD-L1 surface levels. The Knockout line is the standard tool for the former — removing CMTM6 destabilizes PD-L1 and reveals the protein's dependency on this regulator. Overexpression is more useful for asking whether elevating CMTM6 above endogenous levels can further stabilize PD-L1 or rescue PD-L1 surface expression in low-CMTM6 contexts.
For checkpoint biology research, the EDITGENE Knockout line is generally the more informative model because A-375 endogenously expresses both CMTM6 and PD-L1 — the relevant biology is already running, and you are asking what happens when one component is removed. Combining KO with rescue is the gold standard: a clean rescue confirms PD-L1 destabilization is CMTM6-specific and not a clonal artifact.
What are the application scenarios for this model?
Primary applications:
• PD-L1 surface quantification: flow cytometry measurement of membrane PD-L1 under basal and IFN-γ-stimulated conditions. CMTM6 knockout is commonly associated with reduced PD-L1 surface stability.
• T cell co-culture assays: functional immune response readouts in a controlled setting; experimental design should account for variability across tumor-immune systems.
• Checkpoint inhibitor sensitivity: evaluation of how CMTM6 status influences response to PD-1/PD-L1 axis inhibitors.
• Ubiquitination assays: direct assessment of PD-L1 ubiquitination and turnover in the absence of CMTM6.
EDITGENE recommends this model for researchers investigating PD-L1 post-translational regulation, melanoma immune evasion, and checkpoint biology.
Is this cmtm6 Knockout A-375 Cell Line compatible with overexpression rescue experiments?
Yes. CMTM6 is a membrane protein, which introduces specific considerations beyond standard rescue design:
• Construct design: use a codon-modified CMTM6 coding sequence to avoid guide RNA re-targeting. C-terminal tags (HA, FLAG) are generally preferred for membrane proteins; N-terminal tags may interfere with signal peptide processing.
• Subcellular localization control: confirm that exogenous CMTM6 traffics correctly to the plasma membrane by surface staining or membrane fractionation. Mislocalized CMTM6 will not rescue PD-L1 stabilization regardless of expression level.
• Functional readout: rescue should restore PD-L1 surface expression — measured by flow cytometry under both basal and IFN-γ-induced conditions. Restoration of total cellular PD-L1 without surface recovery indicates trafficking failure.
• Delivery method: A-375 transduces efficiently with lentivirus; stable polyclonal pools or single-cell clones are both viable. Clonal selection is recommended for quantitative PD-L1 readouts to minimize cell-to-cell expression variability.
EDITGENE has validated this line's compatibility with standard lentiviral systems and antibiotic selection.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download